Join A Breakthrough Canine Clinical Trial
Biotempus is excited to announce the launch of our clinical trial for Canine cancer patients.
The trial involves mapping the immune cycle of dogs at participating veterinary clinics around Australia.
Owners of dogs with advanced cancer are invited to fill out the short eligibility form to see if they can join our study. Qualified participants will undergo serial blood testing every second day over 2-4 weeks prior to treatment. Blood results will be analyzed by our patented algorithm and a treatment date will be provided to the veterinarian. Treatment consist of a single oral dose of chemotherapy using Cyclophosphamide or Chlorambucil.